291.03

1.62% -4.78

After Hours: 291.40 0.37 +0.13%

Praxis Precision Medicines Inc (PRAX)

Overview News Price History Option Chain Financials Discussions Forecast

Praxis Precision Medicines Inc stock is traded at $291.03, with a volume of 339.74K. It is down -1.62% in the last 24 hours and down -16.98% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Previous Close:

$295.81

Open:

$302.34

24h Volume:

339.74K

Relative Volume:

0.73

Market Cap:

$8.11B

Revenue:

$7.46M

Net Income/Loss:

$-326.53M

P/E Ratio:

-21.75

EPS:

-13.3803

Net Cash Flow:

$-282.53M

1W Performance:

-6.75%

1M Performance:

-16.98%

6M Performance:

-7.40%

1Y Performance:

+420.07%

1-Day Range:

$287.94

$303.75

1-Week Range:

$287.94

$330.00

52-Week Range:

$37.19

$366.52

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name

Praxis Precision Medicines Inc

Sector

Healthcare (1074)

Industry

Biotechnology (598)

Phone

617-300-8460

Address

99 HIGH STREET, 30TH FLOOR, BOSTON

Employee

10,998

Twitter

Next Earnings Date

2026-08-03

Latest SEC Filings

PRAX's Discussions on Twitter

Compare PRAX vs VRTX, REGN, ARGX, RVMD, ALNY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRAX Praxis Precision Medicines Inc	291.03	8.80B	7.46M	-326.53M	-282.53M	-13.38
VRTX Vertex Pharmaceuticals Inc	483.33	121.57B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	695.42	69.95B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	882.56	55.61B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	180.92	39.98B	742.00K	-1.37B	-1.07B	-7.0731
ALNY Alnylam Pharmaceuticals Inc	286.62	37.17B	4.29B	577.22M	641.34M	4.2086

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-13-26	Initiated	Goldman	Buy
Jun-18-26	Initiated	RBC Capital Mkts	Outperform
Apr-10-26	Initiated	Raymond James	Strong Buy
Feb-24-26	Initiated	Wolfe Research	Outperform
Feb-02-26	Initiated	Wells Fargo	Equal Weight
Dec-15-25	Reiterated	Oppenheimer	Outperform
Nov-19-25	Initiated	BTIG Research	Buy
Jun-02-25	Resumed	Oppenheimer	Outperform
May-07-25	Initiated	Chardan Capital Markets	Buy
Mar-03-25	Reiterated	H.C. Wainwright	Buy
Feb-11-25	Initiated	Deutsche Bank	Buy
Aug-05-24	Initiated	Oppenheimer	Outperform
Jun-24-24	Initiated	Needham	Buy
Jun-18-24	Initiated	Guggenheim	Buy
May-01-24	Initiated	Robert W. Baird	Outperform
Sep-19-23	Initiated	Truist	Buy
Jun-06-22	Downgrade	Wedbush	Outperform → Neutral
Dec-16-21	Initiated	H.C. Wainwright	Buy
Aug-26-21	Initiated	BofA Securities	Buy
Apr-26-21	Initiated	William Blair	Outperform
Nov-11-20	Initiated	Wedbush	Outperform
Nov-10-20	Initiated	Cowen	Outperform
Nov-10-20	Initiated	Evercore ISI	Outperform
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

Jul 27, 2026